Ligand Pharmaceuticals Inc (NASDAQ:LGND)

107.74
Delayed Data
As of 4:00pm ET
 +0.43 / +0.40%
Today’s Change
72.57
Today|||52-Week Range
169.98
-30.25%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Major
MARKET CAP
$1.8B

Company Description

Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in Emeryville, CA.

Contact Information

Ligand Pharmaceuticals, Inc.
5980 Horton Street
Emeryville California 94608
P:(858) 550-7500
Investor Relations:
(858) 550-7766

Employees

Shareholders

Mutual fund holders62.53%
Individual stakeholders31.00%
Other institutional29.13%

Top Executives

John L. HigginsChief Executive Officer & Director
Matthew William FoehrPresident & Chief Operating Officer
Matthew Edward KorenbergChief Financial Officer & Executive VP-Finance
Eric VajdaVice President-Preclinical Research & Development
Charles Stuart BerkmanSecretary, Senior Vice President & General Counsel